Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company advancing breakthrough therapies for diseases, today announced the deployment of the OpenAI API to support ...

Hoth Therapeutics has deployed the OpenAI API to support IND-enabling development of HT-KIT, its orphan-designated therapy targeting KIT-driven cancers.

In the open-label PK cohort, 100% of evaluable patients achieved clinical response by Week 6, accompanied by an approximate 50% reduction in investigator-assessed disease severity (using the ARIGA ...

(RTTNews) - Hoth Therapeutics (HOTH) announced its collaboration with OnTargetx R&D to advance research for its cancer-fighting therapeutic, HT-KIT. The study focuses on: development and optimization ...

Star Wars creatures, critters, and robots get lots of appreciation, but what about the imaginative carriages that make all the heroes’ galaxy jetting possible? With Star Wars Wars, The A.V. Club ...

Disney is continuing their countdown to Star Wars Day / aka May the 4th 2025 with a new collection of Hoth-themed apparel and accessories that’s debuting here at Comicbook! As you’re about to see, the ...

Development and optimization of staining methods for (c-Kit) markers, a critical target in HT-KIT therapeutic mechanism. Processing and qualitative evaluation of tissue samples by a board-certified ...

Hoth Therapeutics Inc. (NASDAQ: HOTH) on Tuesday revealed preclinical data from its study on glial cell-derived neurotrophic factor (GDNF) for obesity and metabolic-associated steatotic liver disease ...

NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (HOTH), a patient focused biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to present at ...